Bristol company brings medical innovations to market

Bristol company brings medical innovations to market

P3 Medical Limited specialises in the design, manufacture and marketing of innovative, high-quality medical devices for the global healthcare market.

One example of the company’s success in bringing new innovations to market is Tracheseal, which was designed by three clinicians, along with the help of Health Enterprise East, who identified a need for a specific post-decannulation dressing. Temporary tracheostomies are used in many areas of surgery and anaesthesia. Following decannulation (or removal of the tube), it is important that the tracheostomy wound heals as quickly as possible, preventing any delay which can be problematic for the patient.

Tracheseal is a dedicated dressing to be used after removal of the tracheotomy tube. It allows the patient to communicate better by easily finding their stoma site using the “centre button plate.” This also promotes faster healing of the stoma. P3 Medical’s team of engineers worked closely with the clinicians to help design the button and source an absorbent dressing material. The dressing is now used in several NHS trusts and sold across Europe and the Middle East.

P3 Medical’s headquarters and international distribution centre are based in Bristol. This is also the location of their manufacturing site, fully equipped with four modern cleanrooms. They have a further production and cleanroom facility in Preston in the North West of England.

The firm works closely with clinicians to develop cost-effective solutions which enhance hospital efficiency, patient care and overall safety in operating theatres. They specialise in anaesthesia and airway management, general surgical & equipment drapes (including robotics drapes), gynae & colorectal, wound care & haemostats, and a range of veterinary products.

In addition to marketing their own range, P3 Medical acts as UK distributor to a number of leading medical device manufacturers, bringing innovative products of high quality and value to the NHS and private hospitals. They also export their devices to over 60 countries worldwide and have recently joined the ABHI US Accelerator programme based in Austin, Texas.